GlassScriptPhysician profile
Christen George Botros
NPI 1841011343
$2,552.15
in general payments reported to CMS, 2019-2025
17 companies · $2,282 in 2025
The $2,282 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $271 · 2025: $2,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,552.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $380.53 | 2025 | Qutenza |
| Biotronik Nro, INC. | $352.58 | 2025 | Prospera |
| Vertex Pharmaceuticals Incorporated | $338.46 | 2025 | |
| Collegium Pharmaceutical, INC. | $274.42 | 2025 | Xtampza, Belbuca, Nucynta |
| Abbvie INC. | $225.61 | 2025 | |
| Amgen INC. | $175.89 | 2024-2025 | Repatha, Otezla, Repatha |
| Globus Medical, INC. | $158.80 | 2025 | Senza |
| Forte Bio-Pharma LLC | $127.17 | 2025 | Prolate, Nalocet, Tanlor |
| Astrazeneca Pharmaceuticals LP | $114.38 | 2024 | Airsupra |
| Azurity Pharmaceuticals, INC. | $82.00 | 2025 | Horizant |
| Bioventus LLC | $80.97 | 2025 | Gelsyn-3 |
| Valinor Pharma, LLC | $62.86 | 2025 | Movantik |
| Protega Pharmaceutials INC | $57.65 | 2025 | Roxybond |
| Lundbeck LLC | $56.01 | 2025 | Vyepti |
| Axsome Therapeutics, INC. | $24.37 | 2025 | Symbravo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.09 | 2025 | Proclaim |
| Nalu Medical, INC. | $17.36 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christen Botros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.